These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37778637)

  • 61. Unsupervised learning technique identifies bronchiectasis phenotypes with distinct clinical characteristics.
    Guan WJ; Jiang M; Gao YH; Li HM; Xu G; Zheng JP; Chen RC; Zhong NS
    Int J Tuberc Lung Dis; 2016 Mar; 20(3):402-10. PubMed ID: 27046724
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Chronic cough due to bronchiectasis: ACCP evidence-based clinical practice guidelines.
    Rosen MJ
    Chest; 2006 Jan; 129(1 Suppl):122S-131S. PubMed ID: 16428701
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Non Cystic Fibrosis Bronchiectasis.
    Gupta AK; Lodha R; Kabra SK
    Indian J Pediatr; 2015 Oct; 82(10):938-44. PubMed ID: 26307756
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Chinese expert consensus on the management of lower respiratory tract infections of
    Pulmonary Infection Assembly of Chinese Thoracic Society
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Aug; 45(8):739-752. PubMed ID: 35927044
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Bronchiectasis in a diverse US population: effects of ethnicity on etiology and sputum culture.
    McShane PJ; Naureckas ET; Strek ME
    Chest; 2012 Jul; 142(1):159-167. PubMed ID: 22267679
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [New and Current Concepts of Therapy in Non-CF Bronchiectasis].
    Allewelt M; de Roux A
    Dtsch Med Wochenschr; 2016 May; 141(10):694-9. PubMed ID: 27176062
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Bronchiectasis.
    Subhas E; Rees M
    Aust J Gen Pract; 2022 Dec; 51(12):945-949. PubMed ID: 36451317
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Microbiological changes observed over 48 weeks of treatment with inhaled liposomal ciprofloxacin in individuals with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa lung infection.
    VanDevanter DR; Gonda I; Dahms J; Cipolla D; Davis AM; Chalmers JD; Froehlich J
    Clin Microbiol Infect; 2019 Dec; 25(12):1532-1538. PubMed ID: 31035017
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Bronchiectasis exacerbation: a narrative review of causes, risk factors, management and prevention.
    Choi H; Chalmers JD
    Ann Transl Med; 2023 Jan; 11(1):25. PubMed ID: 36760239
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Spotlight on inhaled ciprofloxacin and its potential in the treatment of non-cystic fibrosis bronchiectasis.
    Chorepsima S; Kechagias KS; Kalimeris G; Triarides NA; Falagas ME
    Drug Des Devel Ther; 2018; 12():4059-4066. PubMed ID: 30568427
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Long-term antibiotic treatment for non-cystic fibrosis bronchiectasis in adults: evidence, current practice and future use.
    Goldman N; Loebinger MR; Wilson R
    Expert Rev Respir Med; 2016 Dec; 10(12):1259-1268. PubMed ID: 27820964
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Treatment of bronchiectasias].
    Purokivi M; Koskela H; Kaarteenaho R
    Duodecim; 2014; 130(8):769-77. PubMed ID: 24822326
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Etiology and characteristics of patients with bronchiectasis in Taiwan: a cohort study from 2002 to 2016.
    Huang HY; Chung FT; Lo CY; Lin HC; Huang YT; Yeh CH; Lin CW; Huang YC; Wang CH
    BMC Pulm Med; 2020 Feb; 20(1):45. PubMed ID: 32070324
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The Pathogenesis of Bronchiectasis.
    Metersky ML; Barker AF
    Clin Chest Med; 2022 Mar; 43(1):35-46. PubMed ID: 35236559
    [TBL] [Abstract][Full Text] [Related]  

  • 75. New therapies for the prevention and treatment of exacerbations of bronchiectasis.
    Abo-Leyah H; Chalmers JD
    Curr Opin Pulm Med; 2017 May; 23(3):218-224. PubMed ID: 28212153
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.
    Bilton D; Henig N; Morrissey B; Gotfried M
    Chest; 2006 Nov; 130(5):1503-10. PubMed ID: 17099030
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study.
    Keir HR; Shoemark A; Dicker AJ; Perea L; Pollock J; Giam YH; Suarez-Cuartin G; Crichton ML; Lonergan M; Oriano M; Cant E; Einarsson GG; Furrie E; Elborn JS; Fong CJ; Finch S; Rogers GB; Blasi F; Sibila O; Aliberti S; Simpson JL; Huang JTJ; Chalmers JD
    Lancet Respir Med; 2021 Aug; 9(8):873-884. PubMed ID: 33609487
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Antimicrobial treatment of non-cystic fibrosis bronchiectasis.
    Grimwood K; Bell SC; Chang AB
    Expert Rev Anti Infect Ther; 2014 Oct; 12(10):1277-96. PubMed ID: 25156239
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Microbiology sampling in non-cystic fibrosis bronchiectasis cases from northern Alberta.
    Wagner MJ; Dimitrov M; Lam GY; Leung W; Tyrrell GJ; Vethanayagam D
    PLoS One; 2023; 18(7):e0288704. PubMed ID: 37450508
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Bronchiectasis in adults: a review.
    Lazarus A; Myers J; Fuhrer G
    Postgrad Med; 2008 Sep; 120(3):113-21. PubMed ID: 18824830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.